Abasaglar ® (basal insulin glargine)

Is Abasaglar® (insulin glargine) safe to use while breastfeeding?

There are no data on the presence of Abasaglar in breast milk nor on its effects on the breastfed infant.


Abasaglar Use While Breast-Feeding

It is unknown whether insulin glargine is excreted in human milk.1

No metabolic effects of ingested insulin glargine on the breast-fed newborn or infant are anticipated since insulin glargine, as a peptide, is digested into amino acids in the human gastrointestinal tract.1

Breast-feeding women may require adjustments in insulin dose and diet.1


1Abasaglar [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.

Date of Last Review: April 06, 2021

Contact Lilly

Call or Email us

If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at ukmedinfo@lilly.com

Available Mon - Fri, 10am - 4pm, excluding Bank Holidays

Or you can

Chat with Us

Click to Chat is Offline

If you have a question, you can chat online with a Lilly Medical Information professional.

Submit a request